{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:39:56Z","timestamp":1792463996131,"version":"4.5.0"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["ID RF-2021-12372851"],"award-info":[{"award-number":["ID RF-2021-12372851"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["Investigator Grant 30315"],"award-info":[{"award-number":["Investigator Grant 30315"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["project PNC0000001"],"award-info":[{"award-number":["project PNC0000001"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02747-x","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:05:17Z","timestamp":1784696717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-derived organoids for precision oncology in colorectal cancer: from tumor modeling to clinical translation"],"prefix":"10.1186","volume":"25","author":[{"given":"Barbara","family":"Lupo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Trusolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"3","key":"2747_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2747_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44(4):222\u201336.","journal-title":"Trends Pharmacol Sci"},{"issue":"7407","key":"2747_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"CGA Network","year":"2012","unstructured":"Network CGA. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330\u20137.","journal-title":"Nature"},{"issue":"10517","key":"2747_CR4","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/S0140-6736(25)02113-0","volume":"406","author":"G Rasschaert","year":"2025","unstructured":"Rasschaert G, Tejpar S. The dawn of immunotherapy in mismatch repair proficient colorectal cancer. Lancet. 2025;406(10517):2302\u20134.","journal-title":"Lancet"},{"issue":"6392","key":"2747_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/359235a0","volume":"359","author":"SM Powell","year":"1992","unstructured":"Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, et al. APC mutations occur early during colorectal tumorigenesis. Nature. 1992;359(6392):235\u20137.","journal-title":"Nature"},{"issue":"6","key":"2747_CR6","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","volume":"138","author":"CR Boland","year":"2010","unstructured":"Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138(6):2073\u2013e873.","journal-title":"Gastroenterology"},{"key":"2747_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejca.2022.07.020","volume":"175","author":"J Taieb","year":"2022","unstructured":"Taieb J, Svrcek M, Cohen R, Basile D, Tougeron D, Phelip JM. Deficient mismatch repair\/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment. Eur J Cancer. 2022;175:136\u201357.","journal-title":"Eur J Cancer"},{"issue":"23","key":"2747_CR8","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, et al. Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer. N Engl J Med. 2020;383(23):2207\u201318.","journal-title":"N Engl J Med"},{"issue":"7","key":"2747_CR9","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/S1470-2045(22)00274-1","volume":"23","author":"C Antoniotti","year":"2022","unstructured":"Antoniotti C, Rossini D, Pietrantonio F, Catteau A, Salvatore L, Lonardi S, et al. Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial. Lancet Oncol. 2022;23(7):876\u201387.","journal-title":"Lancet Oncol"},{"issue":"33","key":"2747_CR10","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1200\/JCO.19.01977","volume":"37","author":"R Sundar","year":"2019","unstructured":"Sundar R, Tan IBH, Chee CE. Negative Predictive Biomarkers in Colorectal Cancer: PRESSING Ahead. J Clin Oncol. 2019;37(33):3066\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2747_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, Arnold D, Normanno N, Ta\u00efeb J, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(1):10\u201332.","journal-title":"Ann Oncol"},{"issue":"17","key":"2747_CR12","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","volume":"359","author":"CS Karapetis","year":"2008","unstructured":"Karapetis CS, Khambata-Ford S, Jonker DJ, O\u2019Callaghan CJ, Tu D, Tebbutt NC, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008;359(17):1757\u201365.","journal-title":"N Engl J Med"},{"issue":"11","key":"2747_CR13","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1056\/NEJMoa1305275","volume":"369","author":"JY Douillard","year":"2013","unstructured":"Douillard JY, Oliner KS, Siena S, Tabernero J, Burkes R, Barugel M, et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med. 2013;369(11):1023\u201334.","journal-title":"N Engl J Med"},{"issue":"8","key":"2747_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","volume":"11","author":"W De Roock","year":"2010","unstructured":"De Roock W, Claes B, Bernasconi D, De Schutter J, Biesmans B, Fountzilas G, et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncol. 2010;11(8):753\u201362.","journal-title":"Lancet Oncol"},{"issue":"6","key":"2747_CR15","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1158\/2159-8290.CD-24-0217","volume":"14","author":"R Yaeger","year":"2024","unstructured":"Yaeger R, Uboha NV, Pelster MS, Bekaii-Saab TS, Barve M, Saltzman J, et al. Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer. Cancer Discov. 2024;14(6):982\u201393.","journal-title":"Cancer Discov"},{"issue":"10","key":"2747_CR16","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1038\/s41591-022-02007-7","volume":"28","author":"J Hallin","year":"2022","unstructured":"Hallin J, Bowcut V, Calinisan A, Briere DM, Hargis L, Engstrom LD, et al. Anti-tumor efficacy of a potent and selective non-covalent KRAS G12D inhibitor. Nat Med. 2022;28(10):2171\u201382.","journal-title":"Nat Med"},{"issue":"20","key":"2747_CR17","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41388-023-02676-9","volume":"42","author":"J Feng","year":"2023","unstructured":"Feng J, Hu Z, Xia X, Liu X, Lian Z, Wang H, et al. Feedback activation of EGFR\/wild-type RAS signaling axis limits KRAS G12D inhibitor efficacy in KRAS G12D -mutated colorectal cancer. Oncogene. 2023;42(20):1620\u201333.","journal-title":"Oncogene"},{"key":"2747_CR18","doi-asserted-by":"crossref","unstructured":"Cremolini C, Chalabi M, Elez E, Fassan M, Gelli M, Go\u00e9r\u00e9 D, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2026;37(6):759\u201376.","DOI":"10.1016\/j.annonc.2026.03.005"},{"issue":"7","key":"2747_CR19","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1158\/2159-8290.CD-20-1531","volume":"11","author":"M Avolio","year":"2021","unstructured":"Avolio M, Trusolino L. Rational Treatment of Metastatic Colorectal Cancer: A Reverse Tale of Men, Mice, and Culture Dishes. Cancer Discov. 2021;11(7):1644\u201360.","journal-title":"Cancer Discov"},{"issue":"7572","key":"2747_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nature14969","volume":"526","author":"A Bertotti","year":"2015","unstructured":"Bertotti A, Papp E, Jones S, Adleff V, Anagnostou V, Lupo B, et al. The genomic landscape of response to EGFR blockade in colorectal cancer. Nature. 2015;526(7572):263\u20137.","journal-title":"Nature"},{"issue":"10","key":"2747_CR21","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1634\/theoncologist.2018-0785","volume":"24","author":"A Sartore-Bianchi","year":"2019","unstructured":"Sartore-Bianchi A, Amatu A, Porcu L, Ghezzi S, Lonardi S, Leone F, et al. HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer. Oncologist. 2019;24(10):1395\u2013402.","journal-title":"Oncologist"},{"issue":"6","key":"2747_CR22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1158\/2159-8290.CD-12-0558","volume":"3","author":"A Bardelli","year":"2013","unstructured":"Bardelli A, Corso S, Bertotti A, Hobor S, Valtorta E, Siravegna G, et al. Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer. Cancer Discov. 2013;3(6):658\u201373.","journal-title":"Cancer Discov"},{"issue":"7404","key":"2747_CR23","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nature11156","volume":"486","author":"S Misale","year":"2012","unstructured":"Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature. 2012;486(7404):532\u20136.","journal-title":"Nature"},{"issue":"7404","key":"2747_CR24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature11219","volume":"486","author":"LA Diaz","year":"2012","unstructured":"Diaz LA, Williams RT, Wu J, Kinde I, Hecht JR, Berlin J, et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature. 2012;486(7404):537\u201340.","journal-title":"Nature"},{"issue":"2","key":"2747_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1158\/2159-8290.CD-15-1283","volume":"6","author":"M Russo","year":"2016","unstructured":"Russo M, Siravegna G, Blaszkowsky LS, Corti G, Crisafulli G, Ahronian LG, et al. Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer. Cancer Discov. 2016;6(2):147\u201353.","journal-title":"Cancer Discov"},{"issue":"25","key":"2747_CR26","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1016\/j.cell.2023.11.006","volume":"186","author":"CN Heiser","year":"2023","unstructured":"Heiser CN, Simmons AJ, Revetta F, McKinley ET, Ramirez-Solano MA, Wang J, et al. Molecular cartography uncovers evolutionary and microenvironmental dynamics in sporadic colorectal tumors. Cell. 2023;186(25):5620\u2013e3716.","journal-title":"Cell"},{"key":"2747_CR27","doi-asserted-by":"publisher","first-page":"1260158","DOI":"10.3389\/fonc.2023.1260158","volume":"13","author":"G Crisafulli","year":"2023","unstructured":"Crisafulli G, Siravegna G, Editorial. The impact of genetics on CRC therapy: from adaptive mutability to drug resistance. Front Oncol. 2023;13:1260158.","journal-title":"Front Oncol"},{"issue":"8102","key":"2747_CR28","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41586-025-09916-w","volume":"650","author":"M White","year":"2026","unstructured":"White M, Mills ML, Millett LM, Gilroy K, Hong Y, Zeiger LB, et al. MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance. Nature. 2026;650(8102):748\u201358.","journal-title":"Nature"},{"issue":"7","key":"2747_CR29","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41588-022-01105-z","volume":"54","author":"M Russo","year":"2022","unstructured":"Russo M, Pompei S, Sogari A, Corigliano M, Crisafulli G, Puliafito A, et al. A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells. Nat Genet. 2022;54(7):976\u201384.","journal-title":"Nat Genet"},{"issue":"6444","key":"2747_CR30","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1126\/science.aaw6985","volume":"364","author":"D Tuveson","year":"2019","unstructured":"Tuveson D, Clevers H. Cancer modeling meets human organoid technology. Science. 2019;364(6444):952\u20135.","journal-title":"Science"},{"issue":"2","key":"2747_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1242\/dev.105.2.223","volume":"105","author":"MH Barcellos-Hoff","year":"1989","unstructured":"Barcellos-Hoff MH, Aggeler J, Ram TG, Bissell MJ. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development. 1989;105(2):223\u201335.","journal-title":"Development"},{"issue":"1","key":"2747_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0022-5193(82)90388-5","volume":"99","author":"MJ Bissell","year":"1982","unstructured":"Bissell MJ, Hall HG, Parry G. How does the extracellular matrix direct gene expression? J Theor Biol. 1982;99(1):31\u201368.","journal-title":"J Theor Biol"},{"issue":"5","key":"2747_CR33","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.stem.2013.04.009","volume":"12","author":"Y Sasai","year":"2013","unstructured":"Sasai Y. Next-generation regenerative medicine: organogenesis from stem cells in 3D culture. Cell Stem Cell. 2013;12(5):520\u201330.","journal-title":"Cell Stem Cell"},{"issue":"7341","key":"2747_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nature09941","volume":"472","author":"M Eiraku","year":"2011","unstructured":"Eiraku M, Takata N, Ishibashi H, Kawada M, Sakakura E, Okuda S, et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature. 2011;472(7341):51\u20136.","journal-title":"Nature"},{"issue":"7467","key":"2747_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, et al. Cerebral organoids model human brain development and microcephaly. Nature. 2013;501(7467):373\u20139.","journal-title":"Nature"},{"issue":"7332","key":"2747_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature09691","volume":"470","author":"JR Spence","year":"2011","unstructured":"Spence JR, Mayhew CN, Rankin SA, Kuhar MF, Vallance JE, Tolle K, et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature. 2011;470(7332):105\u20139.","journal-title":"Nature"},{"issue":"7244","key":"2747_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature07935","volume":"459","author":"T Sato","year":"2009","unstructured":"Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459(7244):262\u20135.","journal-title":"Nature"},{"issue":"1","key":"2747_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.stem.2009.11.013","volume":"6","author":"N Barker","year":"2010","unstructured":"Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, et al. Lgr5(+\u2009ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell. 2010;6(1):25\u201336.","journal-title":"Cell Stem Cell"},{"issue":"1\u20132","key":"2747_CR39","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj SF, Hwang CI, Baker LA, Chio II, Engle DD, Corbo V, et al. Organoid models of human and mouse ductal pancreatic cancer. Cell. 2015;160(1\u20132):324\u201338.","journal-title":"Cell"},{"issue":"7436","key":"2747_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature11826","volume":"494","author":"M Huch","year":"2013","unstructured":"Huch M, Dorrell C, Boj SF, van Es JH, Li VS, van de Wetering M, et al. In vitro expansion of single Lgr5\u2009+\u2009liver stem cells induced by Wnt-driven regeneration. Nature. 2013;494(7436):247\u201350.","journal-title":"Nature"},{"issue":"7","key":"2747_CR41","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","volume":"165","author":"H Clevers","year":"2016","unstructured":"Clevers H. Modeling Development and Disease with Organoids. Cell. 2016;165(7):1586\u201397.","journal-title":"Cell"},{"issue":"7165","key":"2747_CR42","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nature06196","volume":"449","author":"N Barker","year":"2007","unstructured":"Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449(7165):1003\u20137.","journal-title":"Nature"},{"issue":"5","key":"2747_CR43","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","volume":"141","author":"T Sato","year":"2011","unstructured":"Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium. Gastroenterology. 2011;141(5):1762\u201372.","journal-title":"Gastroenterology"},{"issue":"1","key":"2747_CR44","first-page":"103","volume":"77","author":"GB Pierce","year":"1974","unstructured":"Pierce GB. Neoplasms, differentiations and mutations. Am J Pathol. 1974;77(1):103\u201318.","journal-title":"Am J Pathol"},{"issue":"8","key":"2747_CR45","first-page":"1996","volume":"48","author":"GB Pierce","year":"1988","unstructured":"Pierce GB, Speers WC. Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. Cancer Res. 1988;48(8):1996\u20132004.","journal-title":"Cancer Res"},{"issue":"12","key":"2747_CR46","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1016\/j.cell.2024.04.032","volume":"187","author":"AS Patel","year":"2024","unstructured":"Patel AS, Yanai I. A developmental constraint model of cancer cell states and tumor heterogeneity. Cell. 2024;187(12):2907\u201318.","journal-title":"Cell"},{"issue":"6095","key":"2747_CR47","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1126\/science.1224676","volume":"337","author":"AG Schepers","year":"2012","unstructured":"Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, van de Wetering M, et al. Lineage tracing reveals Lgr5\u2009+\u2009stem cell activity in mouse intestinal adenomas. Science. 2012;337(6095):730\u20135.","journal-title":"Science"},{"issue":"7412","key":"2747_CR48","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nature11344","volume":"488","author":"G Driessens","year":"2012","unstructured":"Driessens G, Beck B, Caauwe A, Simons BD, Blanpain C. Defining the mode of tumour growth by clonal analysis. Nature. 2012;488(7412):527\u201330.","journal-title":"Nature"},{"issue":"5","key":"2747_CR49","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759\u201367.","journal-title":"Cell"},{"issue":"6","key":"2747_CR50","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.stem.2016.04.003","volume":"18","author":"M Fujii","year":"2016","unstructured":"Fujii M, Shimokawa M, Date S, Takano A, Matano M, Nanki K, et al. A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis. Cell Stem Cell. 2016;18(6):827\u201338.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"2747_CR51","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F Iorio","year":"2016","unstructured":"Iorio F, Knijnenburg TA, Vis DJ, Bignell GR, Menden MP, Schubert M, et al. A Landscape of Pharmacogenomic Interactions in Cancer. Cell. 2016;166(3):740\u201354.","journal-title":"Cell"},{"issue":"7391","key":"2747_CR52","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nature11005","volume":"483","author":"MJ Garnett","year":"2012","unstructured":"Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A, Lau KW, et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature. 2012;483(7391):570\u20135.","journal-title":"Nature"},{"key":"2747_CR53","doi-asserted-by":"publisher","first-page":"7002","DOI":"10.1038\/ncomms8002","volume":"6","author":"E Medico","year":"2015","unstructured":"Medico E, Russo M, Picco G, Cancelliere C, Valtorta E, Corti G, et al. The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets. Nat Commun. 2015;6:7002.","journal-title":"Nat Commun"},{"issue":"9","key":"2747_CR54","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1158\/0008-5472.CAN-13-2971","volume":"74","author":"JL Wilding","year":"2014","unstructured":"Wilding JL, Bodmer WF. Cancer cell lines for drug discovery and development. Cancer Res. 2014;74(9):2377\u201384.","journal-title":"Cancer Res"},{"issue":"6","key":"2747_CR55","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.cell.2012.02.023","volume":"148","author":"LE Dow","year":"2012","unstructured":"Dow LE, Lowe SW. Life in the fast lane: mammalian disease models in the genomics era. Cell. 2012;148(6):1099\u2013109.","journal-title":"Cell"},{"issue":"12","key":"2747_CR56","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.tcb.2021.07.003","volume":"31","author":"W Hill","year":"2021","unstructured":"Hill W, Caswell DR, Swanton C. Capturing cancer evolution using genetically engineered mouse models (GEMMs). Trends Cell Biol. 2021;31(12):1007\u201318.","journal-title":"Trends Cell Biol"},{"issue":"9","key":"2747_CR57","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","volume":"4","author":"M Hidalgo","year":"2014","unstructured":"Hidalgo M, Amant F, Biankin AV, Budinsk\u00e1 E, Byrne AT, Caldas C, et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014;4(9):998\u20131013.","journal-title":"Cancer Discov"},{"issue":"11","key":"2747_CR58","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41571-022-00682-6","volume":"19","author":"ER Zanella","year":"2022","unstructured":"Zanella ER, Grassi E, Trusolino L. Towards precision oncology with patient-derived xenografts. Nat Rev Clin Oncol. 2022;19(11):719\u201332.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"2747_CR59","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc.2016.140","volume":"17","author":"AT Byrne","year":"2017","unstructured":"Byrne AT, Alf\u00e9rez DG, Amant F, Annibali D, Arribas J, Biankin AV, et al. Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nat Rev Cancer. 2017;17(4):254\u201368.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2747_CR60","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41588-020-00750-6","volume":"53","author":"XY Woo","year":"2021","unstructured":"Woo XY, Giordano J, Srivastava A, Zhao ZM, Lloyd MW, de Bruijn R, et al. Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts. Nat Genet. 2021;53(1):86\u201399.","journal-title":"Nat Genet"},{"issue":"11","key":"2747_CR61","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/ng.3967","volume":"49","author":"U Ben-David","year":"2017","unstructured":"Ben-David U, Ha G, Tseng YY, Greenwald NF, Oh C, Shih J, et al. Patient-derived xenografts undergo mouse-specific tumor evolution. Nat Genet. 2017;49(11):1567\u201375.","journal-title":"Nat Genet"},{"issue":"3","key":"2747_CR62","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41571-022-00721-2","volume":"20","author":"J Chuprin","year":"2023","unstructured":"Chuprin J, Buettner H, Seedhom MO, Greiner DL, Keck JG, Ishikawa F, et al. Humanized mouse models for immuno-oncology research. Nat Rev Clin Oncol. 2023;20(3):192\u2013206.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7550","key":"2747_CR63","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature14415","volume":"521","author":"J Drost","year":"2015","unstructured":"Drost J, van Jaarsveld RH, Ponsioen B, Zimberlin C, van Boxtel R, Buijs A, et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature. 2015;521(7550):43\u20137.","journal-title":"Nature"},{"issue":"5","key":"2747_CR64","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","volume":"7","author":"C Pauli","year":"2017","unstructured":"Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A, et al. Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine. Cancer Discov. 2017;7(5):462\u201377.","journal-title":"Cancer Discov"},{"issue":"8","key":"2747_CR65","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/s41551-023-01154-7","volume":"8","author":"DM Stresser","year":"2024","unstructured":"Stresser DM, Kopec AK, Hewitt P, Hardwick RN, Van Vleet TR, Mahalingaiah PKS, et al. Towards in vitro models for reducing or replacing the use of animals in drug testing. Nat Biomed Eng. 2024;8(8):930\u20135.","journal-title":"Nat Biomed Eng"},{"issue":"20","key":"2747_CR66","doi-asserted-by":"publisher","first-page":"e22276","DOI":"10.1002\/advs.202522276","volume":"13","author":"D Patra","year":"2026","unstructured":"Patra D, Sayed IM, Mukherjee S, Piplani H, Habtezion A, Rosen MJ, et al. Integrating Human Intestinal Organoids into FDA\u2019s New Approach Methodologies for Drug Discovery. Adv Sci (Weinh). 2026;13(20):e22276.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"2747_CR67","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1053\/j.gastro.2008.12.049","volume":"136","author":"MM Taketo","year":"2009","unstructured":"Taketo MM, Edelmann W. Mouse models of colon cancer. Gastroenterology. 2009;136(3):780\u201398.","journal-title":"Gastroenterology"},{"issue":"3","key":"2747_CR68","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nm.3802","volume":"21","author":"M Matano","year":"2015","unstructured":"Matano M, Date S, Shimokawa M, Takano A, Fujii M, Ohta Y, et al. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Nat Med. 2015;21(3):256\u201362.","journal-title":"Nat Med"},{"issue":"12","key":"2747_CR69","doi-asserted-by":"publisher","first-page":"E2357","DOI":"10.1073\/pnas.1701219114","volume":"114","author":"A Fumagalli","year":"2017","unstructured":"Fumagalli A, Drost J, Suijkerbuijk SJ, van Boxtel R, de Ligt J, Offerhaus GJ, et al. Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids. Proc Natl Acad Sci U S A. 2017;114(12):E2357\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2747_CR70","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/nbt.4194","volume":"36","author":"MP Zafra","year":"2018","unstructured":"Zafra MP, Schatoff EM, Katti A, Foronda M, Breinig M, Schweitzer AY, et al. Optimized base editors enable efficient editing in cells, organoids and mice. Nat Biotechnol. 2018;36(9):888\u201393.","journal-title":"Nat Biotechnol"},{"key":"2747_CR71","doi-asserted-by":"crossref","unstructured":"Geurts MH, de Poel E, Pleguezuelos-Manzano C, Oka R, Carrillo L, Andersson-Rolf A, et al. Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids. Life Sci Alliance. 2021;4(10):e202000940.","DOI":"10.26508\/lsa.202000940"},{"issue":"1","key":"2747_CR72","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1038\/s41467-023-40701-3","volume":"14","author":"MH Geurts","year":"2023","unstructured":"Geurts MH, Gandhi S, Boretto MG, Akkerman N, Derks LLM, van Son G, et al. One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids. Nat Commun. 2023;14(1):4998.","journal-title":"Nat Commun"},{"issue":"8011","key":"2747_CR73","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-024-07330-2","volume":"629","author":"LF Lorenzo-Mart\u00edn","year":"2024","unstructured":"Lorenzo-Mart\u00edn LF, H\u00fcbscher T, Bowler AD, Broguiere N, Langer J, Tillard L, et al. Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo. Nature. 2024;629(8011):450\u20137.","journal-title":"Nature"},{"key":"2747_CR74","doi-asserted-by":"publisher","first-page":"573814","DOI":"10.1155\/2015\/573814","volume":"2015","author":"\u0141 Szylberg","year":"2015","unstructured":"Szylberg \u0141, Janiczek M, Popiel A, Marsza\u0142ek A. Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review. Gastroenterol Res Pract. 2015;2015:573814.","journal-title":"Gastroenterol Res Pract"},{"issue":"3","key":"2747_CR75","doi-asserted-by":"publisher","first-page":"254","DOI":"10.5946\/ce.2016.115","volume":"50","author":"YM Lee","year":"2017","unstructured":"Lee YM, Huh KC. Clinical and Biological Features of Interval Colorectal Cancer. Clin Endosc. 2017;50(3):254\u201360.","journal-title":"Clin Endosc"},{"issue":"1","key":"2747_CR76","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.trecan.2023.09.011","volume":"10","author":"A Aiderus","year":"2024","unstructured":"Aiderus A, Barker N, Tergaonkar V. Serrated colorectal cancer: preclinical models and molecular pathways. Trends Cancer. 2024;10(1):76\u201391.","journal-title":"Trends Cancer"},{"issue":"4","key":"2747_CR77","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1136\/gutjnl-2017-315920","volume":"68","author":"TRM Lannagan","year":"2019","unstructured":"Lannagan TRM, Lee YK, Wang T, Roper J, Bettington ML, Fennell L, et al. Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis. Gut. 2019;68(4):684\u201392.","journal-title":"Gut"},{"issue":"3","key":"2747_CR78","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/j.gastro.2019.10.009","volume":"158","author":"K Kawasaki","year":"2020","unstructured":"Kawasaki K, Fujii M, Sugimoto S, Ishikawa K, Matano M, Ohta Y, et al. Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma. Gastroenterology. 2020;158(3):638\u2013e518.","journal-title":"Gastroenterology"},{"issue":"6360","key":"2747_CR79","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1126\/science.aao3130","volume":"358","author":"J Drost","year":"2017","unstructured":"Drost J, van Boxtel R, Blokzijl F, Mizutani T, Sasaki N, Sasselli V, et al. Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer. Science. 2017;358(6360):234\u20138.","journal-title":"Science"},{"issue":"12","key":"2747_CR80","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/s43018-024-00841-x","volume":"5","author":"T Mizutani","year":"2024","unstructured":"Mizutani T, Boretto M, Lim S, Drost J, Gonz\u00e1lez DM, Oka R, et al. Recapitulating the adenoma-carcinoma sequence by selection of four spontaneous oncogenic mutations in mismatch-repair-deficient human colon organoids. Nat Cancer. 2024;5(12):1852\u201367.","journal-title":"Nat Cancer"},{"issue":"7624","key":"2747_CR81","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nature19768","volume":"538","author":"F Blokzijl","year":"2016","unstructured":"Blokzijl F, de Ligt J, Jager M, Sasselli V, Roerink S, Sasaki N, et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature. 2016;538(7624):260\u20134.","journal-title":"Nature"},{"issue":"7702","key":"2747_CR82","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-018-0024-3","volume":"556","author":"SF Roerink","year":"2018","unstructured":"Roerink SF, Sasaki N, Lee-Six H, Young MD, Alexandrov LB, Behjati S, et al. Intra-tumour diversification in colorectal cancer at the single-cell level. Nature. 2018;556(7702):457\u201362.","journal-title":"Nature"},{"issue":"7702","key":"2747_CR83","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/d41586-018-03841-x","volume":"556","author":"CJ Kuo","year":"2018","unstructured":"Kuo CJ, Curtis C. Organoids reveal cancer dynamics. Nature. 2018;556(7702):441\u20132.","journal-title":"Nature"},{"issue":"799","key":"2747_CR84","doi-asserted-by":"publisher","first-page":"eado1641","DOI":"10.1126\/scitranslmed.ado1641","volume":"17","author":"E Grassi","year":"2025","unstructured":"Grassi E, Vurchio V, Cresswell GD, Catalano I, Lupo B, Sassi F, et al. Heterogeneity and evolution of DNA mutation rates in microsatellite stable colorectal cancer. Sci Transl Med. 2025;17(799):eado1641.","journal-title":"Sci Transl Med"},{"issue":"1","key":"2747_CR85","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2018.07.042","volume":"175","author":"KA Knouse","year":"2018","unstructured":"Knouse KA, Lopez KE, Bachofner M, Amon A. Chromosome Segregation Fidelity in Epithelia Requires Tissue Architecture. Cell. 2018;175(1):200\u2013e1113.","journal-title":"Cell"},{"issue":"5","key":"2747_CR86","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41588-019-0399-6","volume":"51","author":"ACF Bolhaqueiro","year":"2019","unstructured":"Bolhaqueiro ACF, Ponsioen B, Bakker B, Klaasen SJ, Kucukkose E, van Jaarsveld RH, et al. Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids. Nat Genet. 2019;51(5):824\u201334.","journal-title":"Nat Genet"},{"issue":"8","key":"2747_CR87","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41588-021-00891-2","volume":"53","author":"Y Bollen","year":"2021","unstructured":"Bollen Y, Stelloo E, van Leenen P, van den Bos M, Ponsioen B, Lu B, et al. Reconstructing single-cell karyotype alterations in colorectal cancer identifies punctuated and gradual diversification patterns. Nat Genet. 2021;53(8):1187\u201395.","journal-title":"Nat Genet"},{"issue":"2","key":"2747_CR88","doi-asserted-by":"publisher","first-page":"100096","DOI":"10.1016\/j.xgen.2022.100096","volume":"2","author":"L Kester","year":"2022","unstructured":"Kester L, de Barbanson B, Lyubimova A, Chen LT, van der Schrier V, Alemany A, et al. Integration of multiple lineage measurements from the same cell reconstructs parallel tumor evolution. Cell Genom. 2022;2(2):100096.","journal-title":"Cell Genom"},{"key":"2747_CR89","doi-asserted-by":"crossref","unstructured":"Buissant des Amorie JR, Hageman JH, Brunner SR, van der Horst SEM, Puschhof MC, van Hoeck A, et al. Emergence of oncofetal plasticity is ubiquitous in early colorectal cancers. Nature. 2026;654(8117):229\u201339.","DOI":"10.1038\/s41586-026-10344-7"},{"issue":"2","key":"2747_CR90","doi-asserted-by":"publisher","first-page":"151478","DOI":"10.1016\/j.ejcb.2025.151478","volume":"104","author":"Y Muta","year":"2025","unstructured":"Muta Y, Nakanishi Y. Mouse colorectal cancer organoids: Lessons from syngeneic and orthotopic transplantation systems. Eur J Cell Biol. 2025;104(2):151478.","journal-title":"Eur J Cell Biol"},{"issue":"7693","key":"2747_CR91","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature25492","volume":"554","author":"DVF Tauriello","year":"2018","unstructured":"Tauriello DVF, Palomo-Ponce S, Stork D, Berenguer-Llergo A, Badia-Ramentol J, Iglesias M, et al. TGF\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis. Nature. 2018;554(7693):538\u201343.","journal-title":"Nature"},{"issue":"7937","key":"2747_CR92","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41586-022-05311-x","volume":"611","author":"J Househam","year":"2022","unstructured":"Househam J, Heide T, Cresswell GD, Spiteri I, Kimberley C, Zapata L, et al. Phenotypic plasticity and genetic control in colorectal cancer evolution. Nature. 2022;611(7937):744\u201353.","journal-title":"Nature"},{"issue":"10","key":"2747_CR93","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/ncb2581","volume":"14","author":"JH van Es","year":"2012","unstructured":"van Es JH, Sato T, van de Wetering M, Lyubimova A, Yee Nee AN, Gregorieff A, et al. Dll1\u2009+\u2009secretory progenitor cells revert to stem cells upon crypt damage. Nat Cell Biol. 2012;14(10):1099\u2013104.","journal-title":"Nat Cell Biol"},{"issue":"7439","key":"2747_CR94","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature11965","volume":"495","author":"SJ Buczacki","year":"2013","unstructured":"Buczacki SJ, Zecchini HI, Nicholson AM, Russell R, Vermeulen L, Kemp R, et al. Intestinal label-retaining cells are secretory precursors expressing Lgr5. Nature. 2013;495(7439):65\u20139.","journal-title":"Nature"},{"issue":"10","key":"2747_CR95","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/nm.2470","volume":"17","author":"P Jung","year":"2011","unstructured":"Jung P, Sato T, Merlos-Su\u00e1rez A, Barriga FM, Iglesias M, Rossell D, et al. Isolation and in vitro expansion of human colonic stem cells. Nat Med. 2011;17(10):1225\u20137.","journal-title":"Nat Med"},{"issue":"6","key":"2747_CR96","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.stem.2017.02.007","volume":"20","author":"FM Barriga","year":"2017","unstructured":"Barriga FM, Montagni E, Mana M, Mendez-Lago M, Hernando-Momblona X, Sevillano M, et al. Mex3a Marks a Slowly Dividing Subpopulation of Lgr5\u2009+\u2009Intestinal Stem Cells. Cell Stem Cell. 2017;20(6):801\u2013. \u2013\u200916.e7.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2747_CR97","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s43018-019-0006-x","volume":"1","author":"K Ganesh","year":"2020","unstructured":"Ganesh K, Basnet H, Kaygusuz Y, Laughney AM, He L, Sharma R, et al. L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer. Nat Cancer. 2020;1(1):28\u201345.","journal-title":"Nat Cancer"},{"issue":"7","key":"2747_CR98","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/s41588-024-01801-y","volume":"56","author":"MP Verhagen","year":"2024","unstructured":"Verhagen MP, Joosten R, Schmitt M, V\u00e4lim\u00e4ki N, Sacchetti A, Rajam\u00e4ki K, et al. Non-stem cell lineages as an alternative origin of intestinal tumorigenesis in the context of inflammation. Nat Genet. 2024;56(7):1456\u201367.","journal-title":"Nat Genet"},{"issue":"7647","key":"2747_CR99","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nature21713","volume":"543","author":"F de Sousa e Melo","year":"2017","unstructured":"de Sousa e Melo F, Kurtova AV, Harnoss JM, Kljavin N, Hoeck JD, Hung J, et al. A distinct role for Lgr5. Nature. 2017;543(7647):676\u201380.","journal-title":"Nature"},{"issue":"7653","key":"2747_CR100","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature22081","volume":"545","author":"M Shimokawa","year":"2017","unstructured":"Shimokawa M, Ohta Y, Nishikori S, Matano M, Takano A, Fujii M, et al. Visualization and targeting of LGR5. Nature. 2017;545(7653):187\u201392.","journal-title":"Nature"},{"issue":"4","key":"2747_CR101","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.stem.2020.02.008","volume":"26","author":"A Fumagalli","year":"2020","unstructured":"Fumagalli A, Oost KC, Kester L, Morgner J, Bornes L, Bruens L, et al. Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer. Cell Stem Cell. 2020;26(4):569\u2013e787.","journal-title":"Cell Stem Cell"},{"issue":"7924","key":"2747_CR102","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41586-022-05043-y","volume":"608","author":"Y Ohta","year":"2022","unstructured":"Ohta Y, Fujii M, Takahashi S, Takano A, Nanki K, Matano M, et al. Cell-matrix interface regulates dormancy in human colon cancer stem cells. Nature. 2022;608(7924):784\u201394.","journal-title":"Nature"},{"issue":"9","key":"2747_CR103","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s43018-022-00402-0","volume":"3","author":"A \u00c1lvarez-Varela","year":"2022","unstructured":"\u00c1lvarez-Varela A, Novellasdemunt L, Barriga FM, Hernando-Momblona X, Ca\u00f1ellas-Socias A, Cano-Crespo S, et al. Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy. Nat Cancer. 2022;3(9):1052\u201370.","journal-title":"Nat Cancer"},{"issue":"7936","key":"2747_CR104","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-022-05402-9","volume":"611","author":"A Ca\u00f1ellas-Socias","year":"2022","unstructured":"Ca\u00f1ellas-Socias A, Cortina C, Hernando-Momblona X, Palomo-Ponce S, Mulholland EJ, Turon G, et al. Metastatic recurrence in colorectal cancer arises from residual EMP1. Nature. 2022;611(7936):603\u201313.","journal-title":"Nature"},{"issue":"8","key":"2747_CR105","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.stem.2022.07.008","volume":"29","author":"EG Vasquez","year":"2022","unstructured":"Vasquez EG, Nasreddin N, Valbuena GN, Mulholland EJ, Belnoue-Davis HL, Eggington HR, et al. Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia. Cell Stem Cell. 2022;29(8):1213\u2013e288.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2747_CR106","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1038\/s41467-022-30382-9","volume":"13","author":"L Sol\u00e9","year":"2022","unstructured":"Sol\u00e9 L, Lobo-Jarne T, \u00c1lvarez-Villanueva D, Alonso-Mara\u00f1\u00f3n J, Guill\u00e9n Y, Guix M, et al. p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis. Nat Commun. 2022;13(1):2866.","journal-title":"Nat Commun"},{"issue":"25","key":"2747_CR107","doi-asserted-by":"publisher","first-page":"7335","DOI":"10.1016\/j.cell.2024.11.023","volume":"187","author":"MR Zapatero","year":"2024","unstructured":"Zapatero MR, Tong A, Opzoomer JW, O\u2019Sullivan R, Rodriguez FC, Sufi J, et al. Trellis tree-based analysis reveals stromal regulation of patient-derived organoid drug responses. Cell. 2024;187(25):7335\u201349.","journal-title":"Cell"},{"issue":"11","key":"2747_CR108","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s43018-020-00130-3","volume":"1","author":"K Ganesh","year":"2020","unstructured":"Ganesh K, Basnet H, Kaygusuz Y, Laughney AM, He L, Sharma R, et al. Author Correction: L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer. Nat Cancer. 2020;1(11):1128.","journal-title":"Nat Cancer"},{"issue":"2","key":"2747_CR109","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1158\/2159-8290.CD-25-0679","volume":"16","author":"A Centonze","year":"2026","unstructured":"Centonze A, Roura AJ, Novillo-Font M, Giordano C, Hernando-Momblona X, Llanses M, et al. A Plastic EMP1\u2009+\u2009to LGR5\u2009+\u2009Cell State Conversion as a Bypass to KRASG12D Pharmacologic Inhibition in Metastatic Colorectal Cancer. Cancer Discov. 2026;16(2):320\u201344.","journal-title":"Cancer Discov"},{"issue":"8047","key":"2747_CR110","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41586-024-08150-0","volume":"637","author":"A Moorman","year":"2025","unstructured":"Moorman A, Benitez EK, Cambulli F, Jiang Q, Mahmoud A, Lumish M, et al. Progressive plasticity during colorectal cancer metastasis. Nature. 2025;637(8047):947\u201354.","journal-title":"Nature"},{"issue":"2","key":"2747_CR111","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41588-024-02058-1","volume":"57","author":"S Mzoughi","year":"2025","unstructured":"Mzoughi S, Schwarz M, Wang X, Demircioglu D, Ulukaya G, Mohammed K, et al. Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer. Nat Genet. 2025;57(2):402\u201312.","journal-title":"Nat Genet"},{"issue":"2","key":"2747_CR112","doi-asserted-by":"publisher","first-page":"105962","DOI":"10.1016\/j.isci.2023.105962","volume":"26","author":"R Coppo","year":"2023","unstructured":"Coppo R, Kondo J, Iida K, Okada M, Onuma K, Tanaka Y, et al. Distinct but interchangeable subpopulations of colorectal cancer cells with different growth fates and drug sensitivity. iScience. 2023;26(2):105962.","journal-title":"iScience"},{"issue":"6","key":"2747_CR113","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.stem.2018.11.016","volume":"23","author":"M Fujii","year":"2018","unstructured":"Fujii M, Matano M, Toshimitsu K, Takano A, Mikami Y, Nishikori S, et al. Human Intestinal Organoids Maintain Self-Renewal Capacity and Cellular Diversity in Niche-Inspired Culture Condition. Cell Stem Cell. 2018;23(6):787\u2013e936.","journal-title":"Cell Stem Cell"},{"issue":"9","key":"2747_CR114","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41422-025-01139-y","volume":"35","author":"L Xiong","year":"2025","unstructured":"Xiong L, Xu Y, Gao Z, Shi J, Wang Y, Wang X, et al. A patient-derived organoid model captures fetal-like plasticity in colorectal cancer. Cell Res. 2025;35(9):642\u201355.","journal-title":"Cell Res"},{"issue":"9","key":"2747_CR115","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.trecan.2024.06.009","volume":"10","author":"X Tang","year":"2024","unstructured":"Tang X, Berger MF, Solit DB. Precision oncology: current and future platforms for treatment selection. Trends Cancer. 2024;10(9):781\u201391.","journal-title":"Trends Cancer"},{"issue":"7291","key":"2747_CR116","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nature08987","volume":"464","author":"TJ Hudson","year":"2010","unstructured":"Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernab\u00e9 RR, et al. International network of cancer genome projects. Nature. 2010;464(7291):993\u20138.","journal-title":"Nature"},{"issue":"1","key":"2747_CR117","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ccell.2017.12.004","volume":"33","author":"R Yaeger","year":"2018","unstructured":"Yaeger R, Chatila WK, Lipsyc MD, Hechtman JF, Cercek A, Sanchez-Vega F, et al. Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer. Cancer Cell. 2018;33(1):125\u2013e363.","journal-title":"Cancer Cell"},{"issue":"11","key":"2747_CR118","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reyni\u00e8s A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350\u20136.","journal-title":"Nat Med"},{"key":"2747_CR119","doi-asserted-by":"publisher","first-page":"15107","DOI":"10.1038\/ncomms15107","volume":"8","author":"C Isella","year":"2017","unstructured":"Isella C, Brundu F, Bellomo SE, Galimi F, Zanella E, Porporato R, et al. Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer. Nat Commun. 2017;8:15107.","journal-title":"Nat Commun"},{"issue":"11","key":"2747_CR120","doi-asserted-by":"publisher","first-page":"105888","DOI":"10.1016\/j.esmoop.2025.105888","volume":"10","author":"R Dienstmann","year":"2025","unstructured":"Dienstmann R, Vivancos A, Nuciforo P, Aguilar S, Ruiz-Pace F, Viaplana C, et al. Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors. ESMO Open. 2025;10(11):105888.","journal-title":"ESMO Open"},{"issue":"1","key":"2747_CR121","doi-asserted-by":"publisher","first-page":"9537","DOI":"10.1038\/s41467-025-64552-2","volume":"16","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Zhang Y, Xu H, Chen Z, Huang S, Li Y, et al. Dynamic clinical trial success rates for drugs in the 21st century. Nat Commun. 2025;16(1):9537.","journal-title":"Nat Commun"},{"issue":"12","key":"2747_CR122","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier L, Mastrogiovanni G, Verstegen MM, Francies HE, Gavarr\u00f3 LM, Bradshaw CR, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med. 2017;23(12):1424\u201335.","journal-title":"Nat Med"},{"issue":"1\u20132","key":"2747_CR123","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, et al. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity. Cell. 2018;172(1\u20132):373\u2013e8610.","journal-title":"Cell"},{"issue":"1","key":"2747_CR124","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","volume":"159","author":"D Gao","year":"2014","unstructured":"Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159(1):176\u201387.","journal-title":"Cell"},{"issue":"1","key":"2747_CR125","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1038\/s41467-019-11867-6","volume":"10","author":"M Kim","year":"2019","unstructured":"Kim M, Mun H, Sung CO, Cho EJ, Jeon HJ, Chun SM, et al. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nat Commun. 2019;10(1):3991.","journal-title":"Nat Commun"},{"issue":"4","key":"2747_CR126","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015;161(4):933\u201345.","journal-title":"Cell"},{"issue":"43","key":"2747_CR127","doi-asserted-by":"publisher","first-page":"13308","DOI":"10.1073\/pnas.1516689112","volume":"112","author":"F Weeber","year":"2015","unstructured":"Weeber F, van de Wetering M, Hoogstraat M, Dijkstra KK, Krijgsman O, Kuilman T, et al. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases. Proc Natl Acad Sci U S A. 2015;112(43):13308\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2747_CR128","doi-asserted-by":"crossref","unstructured":"Jesinghaus M, Silva MG, Zaurito AE, Brunner V, Saab F, Rajamani A, et al. A translational colorectal cancer organoid biobank mirrors patients\u2019 tumor histology, molecular profiles, and treatment responses. J Exp Clin Cancer Res. 2026;45(1):89.","DOI":"10.1186\/s13046-026-03666-x"},{"issue":"12","key":"2747_CR129","doi-asserted-by":"publisher","first-page":"116595","DOI":"10.1016\/j.celrep.2025.116595","volume":"44","author":"H Terai","year":"2025","unstructured":"Terai H, Yasuda H, Sato T. Organoid-based precision cancer modeling: New frontier in lung cancer research. Cell Rep. 2025;44(12):116595.","journal-title":"Cell Rep"},{"issue":"1","key":"2747_CR130","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","volume":"180","author":"F Jacob","year":"2020","unstructured":"Jacob F, Salinas RD, Zhang DY, Nguyen PTT, Schnoll JG, Wong SZH, et al. A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity. Cell. 2020;180(1):188\u2013e20422.","journal-title":"Cell"},{"issue":"52","key":"2747_CR131","doi-asserted-by":"publisher","first-page":"26580","DOI":"10.1073\/pnas.1911273116","volume":"116","author":"E Driehuis","year":"2019","unstructured":"Driehuis E, van Hoeck A, Moore K, Kolders S, Francies HE, Gulersonmez MC, et al. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Proc Natl Acad Sci U S A. 2019;116(52):26580\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2747_CR132","doi-asserted-by":"publisher","first-page":"112212","DOI":"10.1016\/j.celrep.2023.112212","volume":"42","author":"T Ebisudani","year":"2023","unstructured":"Ebisudani T, Hamamoto J, Togasaki K, Mitsuishi A, Sugihara K, Shinozaki T, et al. Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma. Cell Rep. 2023;42(3):112212.","journal-title":"Cell Rep"},{"issue":"5","key":"2747_CR133","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/jgh.15818","volume":"37","author":"RM Engel","year":"2022","unstructured":"Engel RM, Jard\u00e9 T, Oliva K, Kerr G, Chan WH, Hlavca S, et al. Modeling colorectal cancer: A bio-resource of 50 patient-derived organoid lines. J Gastroenterol Hepatol. 2022;37(5):898\u2013907.","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"2747_CR134","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","volume":"18","author":"J Drost","year":"2018","unstructured":"Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer. 2018;18(7):407\u201318.","journal-title":"Nat Rev Cancer"},{"issue":"6378","key":"2747_CR135","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","volume":"359","author":"G Vlachogiannis","year":"2018","unstructured":"Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fern\u00e1ndez-Mateos J, Khan K, et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 2018;359(6378):920\u20136.","journal-title":"Science"},{"key":"2747_CR136","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/scitranslmed.aay2574","volume":"11","author":"SN Ooft","year":"2019","unstructured":"Ooft SN, Weeber F, Dijkstra KK, McLean CM, Kaing S, van Werkhoven E, et al. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients. Sci Transl Med. 2019;11:513.","journal-title":"Sci Transl Med"},{"issue":"14","key":"2747_CR137","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1158\/1078-0432.CCR-20-0073","volume":"26","author":"V Narasimhan","year":"2020","unstructured":"Narasimhan V, Wright JA, Churchill M, Wang T, Rosati R, Lannagan TRM, et al. Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy. Clin Cancer Res. 2020;26(14):3662\u201370.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2747_CR138","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","volume":"25","author":"K Ganesh","year":"2019","unstructured":"Ganesh K, Wu C, O\u2019Rourke KP, Szeglin BC, Zheng Y, Sauv\u00e9 CG, et al. A rectal cancer organoid platform to study individual responses to chemoradiation. Nat Med. 2019;25(10):1607\u201314.","journal-title":"Nat Med"},{"issue":"1","key":"2747_CR139","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","volume":"26","author":"Y Yao","year":"2020","unstructured":"Yao Y, Xu X, Yang L, Zhu J, Wan J, Shen L, et al. Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer. Cell Stem Cell. 2020;26(1):17\u2013e266.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2747_CR140","first-page":"e70067","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel RL, Wagle NS, Star J, Kratzer TB, Smith RA, Jemal A. Colorectal cancer statistics, 2026. CA Cancer J Clin. 2026;76(2):e70067.","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"2747_CR141","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1158\/1078-0432.CCR-25-1564","volume":"31","author":"LP Smabers","year":"2025","unstructured":"Smabers LP, Wensink GE, Verissimo CS, Doorn M, Yang T, Voskuilen T, et al. Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer. Clin Cancer Res. 2025;31(23):5015\u201326.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2747_CR142","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13046-024-02980-6","volume":"43","author":"LP Smabers","year":"2024","unstructured":"Smabers LP, Wensink E, Verissimo CS, Koedoot E, Pitsa KC, Huismans MA, et al. Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response. J Exp Clin Cancer Res. 2024;43(1):61.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"2747_CR143","doi-asserted-by":"publisher","first-page":"100161","DOI":"10.1016\/j.xcrm.2020.100161","volume":"1","author":"S Jiang","year":"2020","unstructured":"Jiang S, Zhao H, Zhang W, Wang J, Liu Y, Cao Y, et al. An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity. Cell Rep Med. 2020;1(9):100161.","journal-title":"Cell Rep Med"},{"issue":"1","key":"2747_CR144","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13046-022-02591-z","volume":"42","author":"F Papaccio","year":"2023","unstructured":"Papaccio F, Garc\u00eda-Mico B, Gimeno-Valiente F, Cabeza-Segura M, Gambardella V, Guti\u00e9rrez-Bravo MF, et al. Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction. J Exp Clin Cancer Res. 2023;42(1):8.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"2747_CR145","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41589-022-00984-x","volume":"18","author":"K Toshimitsu","year":"2022","unstructured":"Toshimitsu K, Takano A, Fujii M, Togasaki K, Matano M, Takahashi S, et al. Organoid screening reveals epigenetic vulnerabilities in human colorectal cancer. Nat Chem Biol. 2022;18(6):605\u201314.","journal-title":"Nat Chem Biol"},{"key":"2747_CR146","doi-asserted-by":"crossref","unstructured":"Alonso S, Chu K, Granowsky E, Rabanales VS, Parsons MJ, Gunasinghe H, et al. Concurrent genetic and non-genetic resistance mechanisms to KRAS inhibition in colorectal cancer. Cancer Cell. 2026;44(7):1368\u201380.e8.","DOI":"10.1016\/j.ccell.2026.04.009"},{"issue":"6","key":"2747_CR147","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/1078-0432.CCR-22-2550","volume":"29","author":"SM Leto","year":"2023","unstructured":"Leto SM, Ferri M, Sassi F, Zanella ER, Cottino F, Vurchio V, et al. Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer. Clin Cancer Res. 2023;29(6):1102\u201313.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2747_CR148","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1158\/2159-8290.CD-24-0556","volume":"16","author":"M Avolio","year":"2026","unstructured":"Avolio M, Leto SM, Sassi F, Lupo B, Grassi E, Catalano I, et al. The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer. Cancer Discov. 2026;16(2):270\u201395.","journal-title":"Cancer Discov"},{"key":"2747_CR149","doi-asserted-by":"publisher","first-page":"14262","DOI":"10.1038\/ncomms14262","volume":"8","author":"M Sch\u00fctte","year":"2017","unstructured":"Sch\u00fctte M, Risch T, Abdavi-Azar N, Boehnke K, Schumacher D, Keil M, et al. Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors. Nat Commun. 2017;8:14262.","journal-title":"Nat Commun"},{"issue":"1","key":"2747_CR150","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.1038\/s41467-024-51909-2","volume":"15","author":"SM Leto","year":"2024","unstructured":"Leto SM, Grassi E, Avolio M, Vurchio V, Cottino F, Ferri M, et al. XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients. Nat Commun. 2024;15(1):7495.","journal-title":"Nat Commun"},{"issue":"3","key":"2747_CR151","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41573-025-01317-y","volume":"25","author":"D Wang","year":"2026","unstructured":"Wang D, Villenave R, Stokar-Regenscheit N, Clevers H. Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges. Nat Rev Drug Discov. 2026;25(3):204\u201326.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"2747_CR152","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s43018-022-00359-0","volume":"3","author":"B Herpers","year":"2022","unstructured":"Herpers B, Eppink B, James MI, Cortina C, Ca\u00f1ellas-Socias A, Boj SF, et al. Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR \u00d7 LGR5 bispecific antibody with efficacy in epithelial tumors. Nat Cancer. 2022;3(4):418\u201336.","journal-title":"Nat Cancer"},{"issue":"10Supplement","key":"2747_CR153","doi-asserted-by":"publisher","first-page":"B033","DOI":"10.1158\/1535-7163.TARG-25-B033","volume":"24","author":"R Khushman Md, Vera","year":"2025","unstructured":"Khushman Md, Vera R, Mazard T, Kendall D, Elez ME, Salva F, et al. Abstract B033: Petosemtamab (MCLA-158) monotherapy or with chemotherapy in metastatic colorectal cancer: Preliminary antitumor activity and safety data from a phase 2 trial. Mol Cancer Ther. 2025;24(10Supplement):B033\u2013B.","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"2747_CR154","doi-asserted-by":"publisher","first-page":"101737","DOI":"10.1016\/j.xcrm.2024.101737","volume":"5","author":"G Mauri","year":"2024","unstructured":"Mauri G, Patelli G, Sartore-Bianchi A, Abrignani S, Bodega B, Marsoni S, et al. Early-onset cancers: Biological bases and clinical implications. Cell Rep Med. 2024;5(9):101737.","journal-title":"Cell Rep Med"},{"issue":"4","key":"2747_CR155","doi-asserted-by":"publisher","first-page":"712","DOI":"10.14309\/ajg.0000000000002171","volume":"118","author":"T Ugai","year":"2023","unstructured":"Ugai T, Haruki K, Harrison TA, Cao Y, Qu C, Chan AT, et al. Molecular Characteristics of Early-Onset Colorectal Cancer According to Detailed Anatomical Locations: Comparison With Later-Onset Cases. Am J Gastroenterol. 2023;118(4):712\u201326.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"2747_CR156","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1136\/gutjnl-2019-320019","volume":"69","author":"HHN Yan","year":"2020","unstructured":"Yan HHN, Siu HC, Ho SL, Yue SSK, Gao Y, Tsui WY, et al. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles. Gut. 2020;69(12):2165\u201379.","journal-title":"Gut"},{"issue":"1","key":"2747_CR157","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12916-023-03034-y","volume":"21","author":"Z Luo","year":"2023","unstructured":"Luo Z, Wang B, Luo F, Guo Y, Jiang N, Wei J, et al. Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening. BMC Med. 2023;21(1):336.","journal-title":"BMC Med"},{"issue":"9","key":"2747_CR158","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.ccell.2021.07.020","volume":"39","author":"V Veninga","year":"2021","unstructured":"Veninga V, Voest EE. Tumor organoids: Opportunities and challenges to guide precision medicine. Cancer Cell. 2021;39(9):1190\u2013201.","journal-title":"Cancer Cell"},{"key":"2747_CR159","doi-asserted-by":"crossref","unstructured":"Mauri G, Durinikova E, Amatu A, Tosi F, Cassingena A, Rizzetto F, et al. Empowering clinical decision making in oligometastatic colorectal cancer: the potential role of drug screening of patient-derived organoids. JCO Precis Oncol. 2021;5:1192\u20139.","DOI":"10.1200\/PO.21.00143"},{"issue":"3","key":"2747_CR160","doi-asserted-by":"publisher","first-page":"100103","DOI":"10.1016\/j.esmoop.2021.100103","volume":"6","author":"SN Ooft","year":"2021","unstructured":"Ooft SN, Weeber F, Schipper L, Dijkstra KK, McLean CM, Kaing S, et al. Prospective experimental treatment of colorectal cancer patients based on organoid drug responses. ESMO Open. 2021;6(3):100103.","journal-title":"ESMO Open"},{"issue":"1","key":"2747_CR161","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13046-023-02683-4","volume":"42","author":"LH Jensen","year":"2023","unstructured":"Jensen LH, Rogatto SR, Lindebjerg J, Havelund B, Abildgaard C, do Canto LM, et al. Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study. J Exp Clin Cancer Res. 2023;42(1):115.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"2747_CR162","doi-asserted-by":"publisher","first-page":"101198","DOI":"10.1016\/j.esmoop.2023.101198","volume":"8","author":"G Martini","year":"2023","unstructured":"Martini G, Belli V, Napolitano S, Ciaramella V, Ciardiello D, Belli A, et al. Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer. ESMO Open. 2023;8(3):101198.","journal-title":"ESMO Open"},{"issue":"12","key":"2747_CR163","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41568-025-00872-1","volume":"25","author":"KB Kennel","year":"2025","unstructured":"Kennel KB, Greten FR. The immune microenvironment of colorectal cancer. Nat Rev Cancer. 2025;25(12):945\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"2747_CR164","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1038\/s41588-025-02380-2","volume":"57","author":"A Henriques","year":"2025","unstructured":"Henriques A, Salvany-Celades M, Nieto P, Palomo-Ponce S, Sevillano M, Hernando-Momblona X, et al. TGF-\u03b2 builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1. Nat Genet. 2025;57(12):3050\u201365.","journal-title":"Nat Genet"},{"issue":"9","key":"2747_CR165","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41575-024-00934-z","volume":"21","author":"A Ca\u00f1ellas-Socias","year":"2024","unstructured":"Ca\u00f1ellas-Socias A, Sancho E, Batlle E. Mechanisms of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol. 2024;21(9):609\u201325.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"2747_CR166","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/annonc\/mdz287","volume":"30","author":"R Dienstmann","year":"2019","unstructured":"Dienstmann R, Villacampa G, Sveen A, Mason MJ, Niedzwiecki D, Nesbakken A, et al. Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II\/III colorectal cancer. Ann Oncol. 2019;30(10):1622\u20139.","journal-title":"Ann Oncol"},{"issue":"3","key":"2747_CR167","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","volume":"19","author":"JJ Havel","year":"2019","unstructured":"Havel JJ, Chowell D, Chan TA. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nat Rev Cancer. 2019;19(3):133\u201350.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"2747_CR168","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","volume":"24","author":"R Polak","year":"2024","unstructured":"Polak R, Zhang ET, Kuo CJ. Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment. Nat Rev Cancer. 2024;24(8):523\u201339.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2747_CR169","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1158\/2159-8290.CD-23-0050","volume":"13","author":"HF Farin","year":"2023","unstructured":"Farin HF, Mosa MH, Ndreshkjana B, Grebbin BM, Ritter B, Menche C, et al. Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses. Cancer Discov. 2023;13(10):2192\u2013211.","journal-title":"Cancer Discov"},{"issue":"7","key":"2747_CR170","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","volume":"175","author":"JT Neal","year":"2018","unstructured":"Neal JT, Li X, Zhu J, Giangarra V, Grzeskowiak CL, Ju J, et al. Organoid Modeling of the Tumor Immune Microenvironment. Cell. 2018;175(7):1972\u2013e8816.","journal-title":"Cell"},{"issue":"6","key":"2747_CR171","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"174","author":"KK Dijkstra","year":"2018","unstructured":"Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF, et al. Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids. Cell. 2018;174(6):1586\u2013e9812.","journal-title":"Cell"},{"issue":"1","key":"2747_CR172","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41587-022-01397-w","volume":"41","author":"JF Dekkers","year":"2023","unstructured":"Dekkers JF, Alieva M, Cleven A, Keramati F, Wezenaar AKL, van Vliet EJ, et al. Uncovering the mode of action of engineered T cells in patient cancer organoids. Nat Biotechnol. 2023;41(1):60\u20139.","journal-title":"Nat Biotechnol"},{"key":"2747_CR173","doi-asserted-by":"publisher","first-page":"1105244","DOI":"10.3389\/fimmu.2023.1105244","volume":"14","author":"B Subtil","year":"2023","unstructured":"Subtil B, Iyer KK, Poel D, Bakkerus L, Gorris MAJ, Escalona JC, et al. Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids. Front Immunol. 2023;14:1105244.","journal-title":"Front Immunol"},{"key":"2747_CR174","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-1-0716-2160-8_17","volume":"2463","author":"IS Chan","year":"2022","unstructured":"Chan IS, Ewald AJ. Organoid Co-culture Methods to Capture Cancer Cell-Natural Killer Cell Interactions. Methods Mol Biol. 2022;2463:235\u201350.","journal-title":"Methods Mol Biol"},{"issue":"23","key":"2747_CR175","doi-asserted-by":"publisher","first-page":"e2200244","DOI":"10.1002\/advs.202200244","volume":"9","author":"L Ning","year":"2022","unstructured":"Ning L, Shim J, Tomov ML, Liu R, Mehta R, Mingee A, et al. A 3D Bioprinted in vitro Model of Neuroblastoma Recapitulates Dynamic Tumor-Endothelial Cell Interactions Contributing to Solid Tumor Aggressive Behavior. Adv Sci (Weinh). 2022;9(23):e2200244.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2747_CR176","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41596-019-0232-9","volume":"15","author":"CM Cattaneo","year":"2020","unstructured":"Cattaneo CM, Dijkstra KK, Fanchi LF, Kelderman S, Kaing S, van Rooij N, et al. Tumor organoid-T-cell coculture systems. Nat Protoc. 2020;15(1):15\u201339.","journal-title":"Nat Protoc"},{"issue":"4","key":"2747_CR177","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","volume":"26","author":"M Chalabi","year":"2020","unstructured":"Chalabi M, Fanchi LF, Dijkstra KK, Van den Berg JG, Aalbers AG, Sikorska K, et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat Med. 2020;26(4):566\u201376.","journal-title":"Nat Med"},{"key":"2747_CR178","doi-asserted-by":"crossref","unstructured":"Schnalzger TE, de Groot MH, Zhang C, Mosa MH, Michels BE, R\u00f6der J, et al. 3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids. EMBO J. 2019;38(12):e100928.","DOI":"10.15252\/embj.2018100928"},{"key":"2747_CR179","doi-asserted-by":"publisher","first-page":"1053920","DOI":"10.3389\/fimmu.2023.1053920","volume":"14","author":"E Strating","year":"2023","unstructured":"Strating E, Verhagen MP, Wensink E, D\u00fcnnebach E, Wijler L, Aranguren I, et al. Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer. Front Immunol. 2023;14:1053920.","journal-title":"Front Immunol"},{"issue":"12","key":"2747_CR180","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41419-024-07266-5","volume":"15","author":"A Esposito","year":"2024","unstructured":"Esposito A, Agostini A, Quero G, Piro G, Priori L, Caggiano A, et al. Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance. Cell Death Dis. 2024;15(12):878.","journal-title":"Cell Death Dis"},{"issue":"6","key":"2747_CR181","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nm.1951","volume":"15","author":"A Ootani","year":"2009","unstructured":"Ootani A, Li X, Sangiorgi E, Ho QT, Ueno H, Toda S, et al. Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche. Nat Med. 2009;15(6):701\u20136.","journal-title":"Nat Med"},{"issue":"7","key":"2747_CR182","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nm.3585","volume":"20","author":"X Li","year":"2014","unstructured":"Li X, Nadauld L, Ootani A, Corney DC, Pai RK, Gevaert O, et al. Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture. Nat Med. 2014;20(7):769\u201377.","journal-title":"Nat Med"},{"key":"2747_CR183","doi-asserted-by":"crossref","unstructured":"C\u00f3rdoba L, Cueto FJ, Cantero-Cid R, Abad-Moret R, D\u00edaz E, \u00c1lvarez-Benayas J, et al. Colorectal air-liquid interface organoids preserve tumour-immune architecture and reveal local treg expansion after PD-1 blockade. Cancers (Basel). 2025;18(1):132.","DOI":"10.3390\/cancers18010132"},{"issue":"6","key":"2747_CR184","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.stem.2022.04.006","volume":"29","author":"S Ding","year":"2022","unstructured":"Ding S, Hsu C, Wang Z, Natesh NR, Millen R, Negrete M, et al. Patient-derived micro-organospheres enable clinical precision oncology. Cell Stem Cell. 2022;29(6):905\u2013e176.","journal-title":"Cell Stem Cell"},{"issue":"16suppl","key":"2747_CR185","doi-asserted-by":"publisher","first-page":"e15574","DOI":"10.1200\/JCO.2023.41.16_suppl.e15574","volume":"41","author":"S Ding","year":"2023","unstructured":"Ding S, Kanikarla Marie P, Baro N, Raman R, Helman E, Hsu SD, et al. Refractory colorectal cancer patient derived MicroOrganoSpheres (MOS) to enable correlation of targeted therapy combination response with clinical outcomes. J Clin Oncol. 2023;41(16suppl):e15574\u2013e.","journal-title":"J Clin Oncol"},{"key":"2747_CR186","doi-asserted-by":"publisher","first-page":"e2500501","DOI":"10.1200\/PO-25-00501","volume":"10","author":"R Gobits","year":"2026","unstructured":"Gobits R, Schleu\u00dfner N, Oliver GR, Rutenberg Schoenberg M, de Jesus Domingues AM, Ramkumar P, et al. Functional Precision Medicine Using MicroOrganoSpheres for Treatment Response Prediction in Advanced Colorectal Cancer. JCO Precis Oncol. 2026;10:e2500501.","journal-title":"JCO Precis Oncol"},{"issue":"2","key":"2747_CR187","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1158\/2159-8290.CD-17-0833","volume":"8","author":"RW Jenkins","year":"2018","unstructured":"Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, et al. Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids. Cancer Discov. 2018;8(2):196\u2013215.","journal-title":"Cancer Discov"},{"issue":"16","key":"2747_CR188","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1002\/cam4.4114","volume":"10","author":"HK Hong","year":"2021","unstructured":"Hong HK, Yun NH, Jeong YL, Park J, Doh J, Lee WY, et al. Establishment of patient-derived organotypic tumor spheroid models for tumor microenvironment modeling. Cancer Med. 2021;10(16):5589\u201398.","journal-title":"Cancer Med"},{"issue":"6","key":"2747_CR189","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nmeth.3853","volume":"13","author":"M Hafner","year":"2016","unstructured":"Hafner M, Niepel M, Chung M, Sorger PK. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs. Nat Methods. 2016;13(6):521\u20137.","journal-title":"Nat Methods"},{"issue":"1","key":"2747_CR190","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1038\/s41467-022-30722-9","volume":"13","author":"J Betge","year":"2022","unstructured":"Betge J, Rindtorff N, Sauer J, Rauscher B, Dingert C, Gaitantzi H, et al. The drug-induced phenotypic landscape of colorectal cancer organoids. Nat Commun. 2022;13(1):3135.","journal-title":"Nat Commun"},{"issue":"1","key":"2747_CR191","doi-asserted-by":"publisher","first-page":"e2420595121","DOI":"10.1073\/pnas.2420595121","volume":"122","author":"JJAP Wijnakker","year":"2025","unstructured":"Wijnakker JJAP, van Son GJF, Krueger D, van de Wetering WJ, Lopez-Iglesias C, Schreurs R, et al. Integrin-activating Yersinia protein Invasin sustains long-term expansion of primary epithelial cells as 2D organoid sheets. Proc Natl Acad Sci U S A. 2025;122(1):e2420595121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2747_CR192","doi-asserted-by":"publisher","first-page":"101376","DOI":"10.1016\/j.xcrm.2023.101376","volume":"5","author":"A Sogari","year":"2024","unstructured":"Sogari A, Rovera E, Grasso G, Mariella E, Reilly NM, Lamba S, et al. Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells. Cell Rep Med. 2024;5(2):101376.","journal-title":"Cell Rep Med"},{"issue":"6356","key":"2747_CR193","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357(6356):1156\u201360.","journal-title":"Science"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02747-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02747-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02747-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:03:35Z","timestamp":1792461815000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02747-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":193,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2747"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02747-x","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"29 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"L.T. has received research grants from Menarini, Merck KGaA, Merus, Pfizer, Servier, and Symphogen. The other authors declare no conflicts.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"246"}}